Heren Health Co.,Ltd. (SHE:300550)
China · Delayed Price · Currency is CNY 11.83
+0.22 (1.89%)
Apr 16, 2026, 4:00 PM EDT
Heren Health Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Revenue | 432.67 | 435.06 | 394.46 | 429.76 | 345.45 | 450.78 |
Other Revenue | - | - | 11.55 | 9.5 | 14.88 | 13.42 |
| 432.67 | 435.06 | 406.01 | 439.25 | 360.33 | 464.2 | |
Revenue Growth (YoY) | 10.02% | 7.15% | -7.57% | 21.90% | -22.38% | 2.08% |
Cost of Revenue | 229.4 | 232.16 | 218.11 | 270.29 | 288.73 | 305.7 |
Gross Profit | 203.28 | 202.89 | 187.9 | 168.96 | 71.6 | 158.5 |
Selling, General & Admin | 75.2 | 74.43 | 62.49 | 78.98 | 80.99 | 66.03 |
Research & Development | 53.57 | 53.1 | 52.52 | 53.81 | 54.05 | 53.83 |
Other Operating Expenses | -6.83 | -8.94 | -1.66 | -9.85 | -5.17 | -2.15 |
Operating Expenses | 121.94 | 118.59 | 158.23 | 142.82 | 169.16 | 135.15 |
Operating Income | 81.34 | 84.3 | 29.67 | 26.14 | -97.56 | 23.35 |
Interest Expense | - | - | -4.27 | -3.86 | -3.49 | -2.53 |
Interest & Investment Income | 1.72 | 1.27 | 10.6 | 15.33 | 11.7 | 13.76 |
Other Non Operating Income (Expenses) | -15.2 | -12.98 | -0.82 | 2.3 | -0.08 | -0.21 |
EBT Excluding Unusual Items | 67.86 | 72.59 | 35.19 | 39.9 | -89.43 | 34.37 |
Gain (Loss) on Sale of Investments | 0.92 | 0.74 | 0.82 | 0.72 | 0.14 | - |
Gain (Loss) on Sale of Assets | -0.02 | -0.02 | 0.12 | -0.1 | -0.04 | -0.04 |
Asset Writedown | -23.64 | -23.17 | -0.06 | -0.01 | -6.87 | -0.08 |
Other Unusual Items | - | - | 1.35 | 0.46 | 1.14 | 0.69 |
Pretax Income | 45.12 | 50.14 | 37.43 | 40.97 | -95.05 | 34.94 |
Income Tax Expense | 0.41 | 2.13 | 0.13 | 2.05 | -10.85 | 0.65 |
Earnings From Continuing Operations | 44.71 | 48.01 | 37.3 | 38.92 | -84.2 | 34.29 |
Minority Interest in Earnings | -2.38 | -0.34 | 2 | 0.19 | 0.89 | 0.19 |
Net Income | 42.32 | 47.66 | 39.3 | 39.12 | -83.31 | 34.48 |
Net Income to Common | 42.32 | 47.66 | 39.3 | 39.12 | -83.31 | 34.48 |
Net Income Growth | 17.67% | 21.29% | 0.46% | - | - | -20.08% |
Shares Outstanding (Basic) | 265 | 265 | 262 | 261 | 260 | 265 |
Shares Outstanding (Diluted) | 265 | 265 | 262 | 261 | 260 | 265 |
Shares Change (YoY) | 0.49% | 1.08% | 0.46% | 0.17% | -1.85% | 10.66% |
EPS (Basic) | 0.16 | 0.18 | 0.15 | 0.15 | -0.32 | 0.13 |
EPS (Diluted) | 0.16 | 0.18 | 0.15 | 0.15 | -0.32 | 0.13 |
EPS Growth | 17.09% | 20.00% | - | - | - | -27.78% |
Free Cash Flow | 56.77 | 83.92 | -37.95 | 58.51 | -126.31 | -94.38 |
Free Cash Flow Per Share | 0.21 | 0.32 | -0.14 | 0.22 | -0.48 | -0.36 |
Dividend Per Share | - | - | 0.025 | 0.030 | - | 0.020 |
Dividend Growth | - | - | -16.67% | - | - | -20.00% |
Gross Margin | 46.98% | 46.64% | 46.28% | 38.47% | 19.87% | 34.14% |
Operating Margin | 18.80% | 19.38% | 7.31% | 5.95% | -27.08% | 5.03% |
Profit Margin | 9.78% | 10.96% | 9.68% | 8.91% | -23.12% | 7.43% |
Free Cash Flow Margin | 13.12% | 19.29% | -9.35% | 13.32% | -35.05% | -20.33% |
EBITDA | 113.83 | 112.46 | 40.47 | 57 | -68.87 | 41.22 |
EBITDA Margin | 26.31% | 25.85% | 9.97% | 12.98% | -19.11% | 8.88% |
D&A For EBITDA | 32.49 | 28.15 | 10.8 | 30.86 | 28.7 | 17.86 |
EBIT | 81.34 | 84.3 | 29.67 | 26.14 | -97.56 | 23.35 |
EBIT Margin | 18.80% | 19.38% | 7.31% | 5.95% | -27.08% | 5.03% |
Effective Tax Rate | 0.91% | 4.25% | 0.34% | 5.00% | - | 1.86% |
Revenue as Reported | - | - | 406.01 | 439.25 | 360.33 | 464.2 |
Advertising Expenses | - | - | - | - | - | 1.01 |
Updated Mar 31, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.